APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024By ApyxMedical|2025-12-12T18:05:38+00:00April 25, 2024|
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMITBy ApyxMedical|2025-12-12T18:06:03+00:00April 11, 2024|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T18:06:50+00:00March 21, 2024|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024By ApyxMedical|2025-12-12T18:07:17+00:00March 4, 2024|
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETINGBy ApyxMedical|2025-12-12T18:07:44+00:00February 21, 2024|
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODYBy ApyxMedical|2025-12-12T18:08:11+00:00January 22, 2024|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTSBy ApyxMedical|2025-12-12T18:12:35+00:00January 8, 2024|
